Patents Assigned to STEM CELL PARTNERS LLC
  • Patent number: 9480730
    Abstract: A method for preparing thrombin serum, the method comprising obtaining blood fluid sample, contacting a first aliquot of the blood fluid with a procoagulant agent to form prothrombinase enzyme complex bound to the surface of the procoagulant agent so as to obtain an activated procoagulant agent that may be stored. The activated procoagulant agent may then be contacted with a second aliquot of the blood fluid containing prothrombin so as to obtain thrombin serum, which may be extracted and contacted with fibrinogen to obtain fibrin.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: November 1, 2016
    Assignee: Stem Cell Partners LLC
    Inventor: John R. Chapman
  • Publication number: 20120213754
    Abstract: An apparatus for the preparation of cells for implantation into a living body is disclosed. The apparatus comprises a vessel substantially impermeable to gaseous oxygen; and fluid within said vessel, the fluid having a maximal dissolved oxygen capacity substantially equivalent to normal saline yet having a hypoxic oxygen concentration between about 0% to about 5% of said maximal dissolved oxygen capacity. The bag oxygen concentration level remains low when the apparatus is stored at 22°-25° C. in normal atmospheric conditions for a period of at least 30 days. The present invention simplifies the process of achieving donor cell hypoxic preconditioning for cell implantation, and may be used to bathe said cells to be transplanted for a sufficient time to activate the hypoxic metabolic pathway.
    Type: Application
    Filed: February 16, 2012
    Publication date: August 23, 2012
    Applicant: STEM CELL PARTNERS LLC
    Inventor: John R. Chapman